ArticleThe Journal of innovations in cardiac rhythm management2025
Successful Cardiac Resynchronization Therapy Defibrillator Implantation via the Vein of Marshall in a Patient with Coronary Sinus Ostial Occlusion.
Article in The Journal of innovations in cardiac rhythm management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Letter from the Editor in Chief.The Journal of innovations in cardiac rhythm management · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac resynchronization therapy (CRT) is a well-established treatment for patients with heart failure and wide QRS complexes. Successful left ventricular (LV) lead implantation is typically achieved through the coronary sinus (CS). However, congenital anomalies such as CS ostial atresia can complicate the procedure. We report a case of a 65-year-old man with a history of aortic valve replacement and heart failure who underwent successful CRT-defibrillator implantation. During the procedure, CS ostial atresia was unexpectedly encountered, preventing standard venous access. The LV lead was successfully implanted via the vein of Marshall.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.